Planning Committees

Cindy Welsh, MD (admin co-lead)

Medical Officer

RDT, DRDMG, ORPURM, OND, CDER

Cynthia Rothblum-Oviatt, PhD (admin co-lead)

Science Policy Analyst

RDT, DRDMG, ORPURM, OND, CDER

Drea Bell-Vlasov, PhD (admin backup)

Science Policy Analyst

RDT, DRDMG, ORPURM, OND, CDER

Julienne (Julie) Vaillancourt, RPh, MPH

Senior Regulatory Health Pr

Office of the Center Director, CBER

Anne Rowzee, PhD

ADP – Stakeholder Engagement

Office of Therapeutic Products, CBER

Brittany Schuck, PhD

Deputy Office Director, Office of In Vitro Diagnostics, CDRH

Erika Torjusen, MD, MHS

Director of HUD, PDC and RPD Programs

Office of Orphan Products Development, OCPP, OC

Philip J. Brooks, PhD

Acting Director

Division of Rare Diseases Research Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

Sarah Cortell Vandersypen

Executive Director

United MSD Foundation

Kate Donigan

Executive Director, Science & Regulatory Policy

Global Policy, Government, & Patient Affairs, Sarepta Therapeutics

Kevin E. Glinton, MD, PhD

Assistant Professor, Department of Molecular and Human Genetics Chief, Genetics Service

Ben Taub Hospital-Smith Clinic Baylor College of Medicine | Texas Children's Hospital | Harris Health Director at Baylor College of Medicine, NORD RD CoE

Evie Li

Medical Student, Carver College of Medicine

California Ambassador, NORD Rare Action Network^®

Brian Portela

Founder and Vice President of Students for Rare Chapter

UConn School of Pharmacy

Meera A. Shah, MPH

Health Specialist

National Center for Advancing Translational Sciences National Institutes of Health